TY - JOUR
T1 - Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II
T2 - Clinical, Technical, and Socioeconomic Considerations
AU - Aljurf, Mahmoud
AU - Weisdorf, Daniel
AU - Hashmi, Shahrukh
AU - Nassar, Amr
AU - Gluckman, Eliane
AU - Mohty, Mohamad
AU - Rizzo, Doug
AU - Pasquini, Marcelo
AU - Hamadani, Mehdi
AU - Saber, Wael
AU - Hari, Parameswaran
AU - Kharfan-Dabaja, Mohamed
AU - Majhail, Navneet
AU - Gerges, Usama
AU - Hamidieh, Amir Ali
AU - Hussain, Fazal
AU - Elhaddad, Alaa
AU - Mahmoud, Hossam K.
AU - Tbakhi, Abdelghani
AU - Othman, Tarek Ben
AU - Hamladji, Rose Marie
AU - Bekadja, Mohamed Amine
AU - Ahmed, Parvez
AU - Bazarbachi, Ali
AU - Adil, Salman
AU - Alkindi, Salman
AU - Ladeb, Saleh
AU - Dennison, David
AU - Patel, Moosa
AU - Lu, Peihua
AU - Quessar, Asma El
AU - Okamoto, Shinichiro
AU - Atsuta, Yoshiko
AU - Alhejazi, Ayman
AU - Ayas, Mouhab F.
AU - Ahmed, Syed O.
AU - Novitzky, Nickolas
AU - Srivastava, Alok
AU - Seber, Adriana
AU - Solh, Hassan El
AU - Ghavamzadeh, Ardeshir
AU - Confer, Dennis
AU - Kodera, Yoshihisa
AU - Hildegard, Greinix
AU - Szer, Jeff
AU - Horowitz, Mary M.
AU - Niederwieser, Dietger
N1 - Publisher Copyright:
© 2019 American Society for Blood and Marrow Transplantation
PY - 2019/12
Y1 - 2019/12
N2 - The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings.
AB - The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings.
KW - Bone marrow transplantation
KW - Developing countries
KW - Low-income countries
UR - http://www.scopus.com/inward/record.url?scp=85065760511&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065760511&partnerID=8YFLogxK
U2 - 10.1016/j.bbmt.2019.04.012
DO - 10.1016/j.bbmt.2019.04.012
M3 - Review article
C2 - 31002990
AN - SCOPUS:85065760511
SN - 1083-8791
VL - 25
SP - 2330
EP - 2337
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
IS - 12
ER -